Analisis Survival: Hubungan Konversi Sputum dengan Keberhasilan Pengobatan Pasien Tuberkulosis Resistan Obat di Indonesia
Abstract
Keywords
Full Text:
PDFReferences
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan RI No.67 Tahun 2016 [Internet]. Jakarta: Kementerian Kesehatan RI; 2016 [cited 2023 Mar 20]. Available from: https://tbindonesia.or.id/pustaka_tbc/peraturan-republik-indonesia-nomor-67-tahun-2016-tentang-penanggulangan-tuberkulosis/
World Health Organization. Global Tuberculosis Report 2022 [Internet]. Geneva: World Health Organization; 2022 [cited 2023 Mar 20]. Available from: https://www.who.int/publications/i/item/9789240061729]
Kementerian Kesehatan RI. Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024 [Internet]. 2020 [cited 2023 Mar 20]. Available from: https://tbindonesia.or.id/wp-content/uploads/2021/06/NSP-TB-2020-2024-Ind_Final_-BAHASA.pdf
World Health Organization. WHO Treatment Guidelines for Drug-Resistant Tuberculosis [Internet]. Geneva: World Health Organization; [cited 2023 Mar 20]. Available from: https://www.who.int/publications/i/item/9789241549639
Lu P, Liu Q, Martinez L, Yang H, Lu W, Ding X, et al. Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China. Eur Respir J. 2017 Mar;49(3):1601558.
Nakamura Y, Yamasue M, Komiya K, Takikawa S, Hiramatsu K, Kadota J ichi. Association between sputum conversion and in-hospital mortality in elderly patients with pulmonary tuberculosis: a retrospective study. BMC Infect Dis. 2022 Dec;22(1):339.
Alemu A, Bitew ZW, Worku T, Gamtesa DF, Alebel A. Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis. Sabol I, editor. PLoS ONE. 2021 Jun 28;16(6):e0253848.
Viana PVDS, Paiva NS, Villela DAM, Bastos LS, De Souza Bierrenbach AL, Basta PC. Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis. Horne DJ, editor. PLoS ONE. 2020 Oct 8;15(10):e0240090.
Muluneh MA, Zeru AB, Derseh BT, Molla Kebede A. Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia. Sistanizad M, editor. Canadian Journal of Infectious Diseases and Medical Microbiology. 2021 Sep 3;2021:1–9.
Ma JB, Zeng LC, Ren F, Dang LY, Luo H, Wu YQ, et al. Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi’an China, a Retrospective Cohort Study. IDR. 2022 Aug;Volume 15:4947–57.
Velayutham B, Nair D, Kannan T, Padmapriyadarsini C, Sachdeva KS, Bency J, et al. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis. Int J Tuberc Lung Dis [Internet]. 2016 [cited 2023 May 13]; Available from: https://pubmed.ncbi.nlm.nih.gov/27931345/
Wahid A, Ghafoor A, Khan AW, Al-Worafi YM, Latif A, Shahwani NA, et al. Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country. Front Pharmacol. 2022 Sep 6;13:973713.
Kementerian Kesehatan RI. Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat di Indonesia. Jakarta: Kementerian Kesehatan RI; 2020.
Kementerian Kesehatan RI. Laporan Program Penanggulangan Tuberkulosis 2021 [Internet]. Jakarta: Kementerian Kesehatan RI; 2022 [cited 2023 May 25]. Available from: https://tbindonesia.or.id/pustaka_tbc/laporan-tahunan-program-tbc-2021/
Afifah RA. Determinan Keberhasilan Pengobatan Tuberkulosis Resistan Obat di Provinsi DKI Jakarta Tahun 2014-2015. [Depok]: Universitas Indonesia; 2018.
Iswati E. Hubungan Konversi Kultur Sputum pada 3 Bulan Pengobatan dengan Sukses Pengobatan Multi Drug Resistan Tuberculosis (TB MDR) di Indonesia Tahun 2014-2015. [Depok]: Fakultas Kesehatan Masyarakat Universitas Indonesia; 2018.
Kementerian Kesehatan RI. Dashboard TB Indonesia [Internet]. 2023 [cited 2023 May 25]. Available from: https://tbindonesia.or.id/pustaka-tbc/dashboard/
Asemahagn MA. Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: a longitudinal study. BMC Pulm Med. 2021 Dec;21(1):118.
Turner RD, Chiu C, Churchyard GJ, Esmail H, Lewinsohn DM, Gandhi NR, et al. Tuberculosis Infectiousness and Host Susceptibility. The Journal of Infectious Diseases. 2017 Nov 3;216(suppl_6):S636–43.
Dylan B T, Molly F F, Mercedes C B, Felix A AV, Cesar A B, Epifanio Sanchez, et al. Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment. PLOS ONE. 2014 Sep 19;9(9).
Akatukwasa C, Getahun M, El Ayadi AM, Namanya J, Maeri I, Itiakorit H, et al. Dimensions of HIV-related stigma in rural communities in Kenya and Uganda at the start of a large HIV ‘test and treat’ trial. Price MA, editor. PLoS ONE. 2021 May 17;16(5):e0249462.
Maitre T, Petitjean G, Chauffour A, Bernard C, El Helali N, Jarlier V, et al. Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis? Journal of Antimicrobial Chemotherapy. 2017 Aug 1;72(8):2326–33.
Du Y, Qiu C, Chen X, Wang J, Jing W, Pan H, et al. Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China. Clinical Infectious Diseases. 2020 Aug 14;71(4):1047–54.
DOI: http://dx.doi.org/10.7454/epidkes.v7i1.6955
Refbacks
- There are currently no refbacks.